Lameda V.
54
Coauthors
5
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 2 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Infección | 2 |
| Nutrición | 1 |
| Metabolismo | 1 |
| Salud mental | 1 |
| Enfermedad cardiovascular | 1 |
| Medicina interna | 1 |
| Salud Pública | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 4 |
| Salud y seguridad personal | 2 |
| Farmacología y terapéutica | 2 |
| Fisiología humana | 1 |
| Problemas sociales y servicios a grupos | 1 |
| Fisiología y materias afines | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 5 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Valmore Bermúdez | 5 |
| Nava M. | 3 |
| Torres W. | 3 |
| Suarez M.K. | 2 |
| Manzano A. | 2 |
| Rojas E.R. | 2 |
| Ortega A. | 2 |
| Rojas-Quintero J. | 2 |
| Salazar-Vílchez J. | 2 |
| Ramírez P. | 2 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Diagnostic criteria and management of metabolic syndrome: Evolution overtime
ReviewAbstract: The beginnings of the Metabolic Syndrome (MetS) as a suspected, not yet recognized entity can be traPalabras claves:Cardiovascular disease, Diagnostic criteria, management, Metabolic syndrome, MetS updates, Type 2 DiabetesAutores:Carrasquero R., Castro A., Lameda V., Manzano A., Nava M., Rojas E.R., Suarez M.K., Valmore BermúdezFuentes:scopusMetabolic risk in depression and treatment with selective serotonin reuptake inhibitors: are the metabolic syndrome and an increase in cardiovascular risk unavoidable?
ReviewAbstract: Depression is one of the most common psychiatric disorders, and has become an epidemic in modern medPalabras claves:Cardiovascular disease, Cardiovascular Risk, Chronic inflammation, Depression, Metabolic syndrome, Selective serotonin reuptake inhibitors, Type 2 Diabetes mellitusAutores:Chávez-Castillo M., Fuenmayor J., Lameda V., Nava M., Ortega A., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusPathogenic mechanisms of SARS-CoV-2 infection and kidney disease: a clinical and molecular perspective
ArticleAbstract: The SARS-CoV-2 infection has become as a worldwide public health emergency. It exhibits a variety ofPalabras claves:acute kidney injury, Angiotensin-conver-ting enzyme 2, Chronic kidney disease, covid-19, SARS-COV-2Autores:D’marco L., Guerra-Torres X.E., Lameda V., Manzano A., Medina O., Morillo V., Nava M., Parra H., Puchades M.J., Suarez M.K., Torres W., Valmore BermúdezFuentes:scopusPrevalence of physical inactivity and associated cardiometabolic risk factors: A cross-sectional study
ArticleAbstract: Background: Physical inactivity represents a public health problem associated with non-communicablePalabras claves:Leisure time, Physical inactivity, risk factor, sedentary, transportationAutores:Añez-Ramos R., Galbán N., Gallo V., González M.C., Lameda V., Luzardo E., Olivar L.C., Ponce C.C., Ramírez P., Rojas M., Salazar-Vílchez J., Torres W., Valmore BermúdezFuentes:scopusNon-HDL cholesterol is better than ldl-c at pbkp_redicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report from a venezuelan population
ArticleAbstract: Background: Non-high density lipoprotein cholesterol (non-HDL-c) has emerged as an important tool inPalabras claves:ASCVD, cholesterol, Coronary artery disease, LDL-c, Non-HDL-c, risk factorAutores:de Bravo M.C., D’Addosio R., Graterol M., Graterol R., Hoedebecke K., Lameda V., Martínez M.S., Olivar L.C., Ortega A., Ramírez P., Rastogi S., Rojas E.R., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Wilches S.Fuentes:scopus